Allogene Therapeutics, Inc. (ALLO)
After hours:
- GlobeNewswire
Allogene Therapeutics Announces Participation in September Investor Conference
SOUTH SAN FRANCISCO, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer, today announced that it will participate in an upcoming investor conference in September. Baird 2023 Global Healthcare ConferenceTuesday, September 12, 202312:45PM PT/3:45PM ET Any available webcasts will be posted to the Company's website at www.allogene.com under the In
- Insider Monkey
16 Most Shorted Stocks Right Now
In this piece, we will take a look at the 16 most shorted stocks right now. If you want to skip our introduction to short selling, then take a look at 5 Most Shorted Stocks Right Now. One of the most intriguing plays on the stock market is short selling. This is because it goes […]
- Insider Monkey
11 Best High Short Interest Stocks To Buy Now
In this piece, we will take a look at the 11 best high short interest stocks to buy now. If you want to skip our introduction to short selling and short interest, then take a look at 5 Best High Short Interest Stocks To Buy Now. Short selling is one of the most controversial practices […]
